Wolverine Trading, LLC Astria Therapeutics, Inc. Call Options Transaction History

Wolverine Trading, LLC

  • $94.2 Billion
  • Q2 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 15, 2024
BUY
$6.99 - $16.69 $146,091 - $348,821
20,900 New
20,900 $294,000
Q2 2022

Aug 15, 2022
SELL
$2.46 - $6.96 $113,652 - $321,552
-46,200 Reduced 76.49%
14,200 $42,000
Q1 2022

May 16, 2022
SELL
$3.92 - $7.1 $18,032 - $32,660
-4,600 Reduced 7.08%
60,400 $420,000
Q4 2021

Feb 14, 2022
BUY
$5.08 - $8.62 $330,200 - $560,300
65,000 New
65,000 $330,000

Others Institutions Holding ATXS

# of Institutions
104
Shares Held
49.4M
Call Options Held
27.6K
Put Options Held
29.7K
View Full List

About Astria Therapeutics, Inc.

ATXS Quotes by TradingView
  • Ticker ATXS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 15,178,000
  • Market Cap $182M
  • Description
  • Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare and niche allergic, and immunological diseases in the United States. Its lead product candidate is STAR-0215, a monoclonal antibody inhibitor of plasma kallikrein, which is in preclinical development stage...
More about ATXS
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email